More frequently reported side effectsinclude: headache. Continue reading for a comprehensive list of adverse effects. Applies to ustekinumab: parenteral injection, parenteral injection concentrate. Side effects include: Patients with psoriasis (≥3%): Nasopharyngitis, upper respiratory tract infection, headache, … See more Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Some side effects may not be … See more WebNov 11, 2024 · Weight gain or weight loss (not a side effect) In clinical studies, weight gain and weight loss weren’t reported as side effects of Stelara. However, weight loss can be a …
Ustekinumab — Arthritis Australia
WebUstekinumab is an antibody that blocks p40 and thereby interleukins 12 and 23. Trials showed promising results in treating IBD patients with this drug. Consequently, ... who were refractory to conventional respond or had side effects. They received 130 mg or 6 mg/kg ustekinumab or placebo intravenously. IM-UNITI included 397 patients, ... WebJun 27, 2024 · STELARA ® is not for everyone; only your doctor can decide if it's right for you. STELARA ® is a prescription medicine that affects your immune system. It can … noteworthy information
ustekinumab (Stelara): Psoriasis Drug Side Effects & Dosage
WebJul 5, 2024 · For more information on mild side effects of the two drugs, see the prescribing information for Cosentyx and Stelara. ... (ustekinumab) injection, for subcutaneous or intravenous use. (2024) ... WebStelara is an FDA-approved medication manufactured by Janssen Biotech, Inc. It is classed as a biologic immunosuppressant used to treat inflammatory diseases. While Stelara is generally well tolerated, there are some potential side effects that people should be aware of. The most common side effects of Stelara include injection site reactions and infections. WebStelara: Ustekinumab belongs to the class of medications called selective immunomodulating agents, also known as biologics. It is used to treat chronic, moderate-to-severe plaque psoriasis for adults who are candidates for phototherapy or systemic therapy. It is also used for children and adolescents 6 to 17 years old who can't tolerate other … noteworthy information crossword